Catalog No.
DHD14219
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
IgG
Clonality
Monoclonal
Applications
Research Grade Biosimilar
Target
PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P15941
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
SPmAb2.1
Clone ID
SPmAb2.1
Note
For research use only. Not suitable for clinical or therapeutic use.
Differential Glycoform Analysis of MUC1 Derived from Biological Specimens Using an Antibody-Overlay Lectin Microarray., PMID:38347414
Solution NMR Analysis of O-Glycopeptide-Antibody Interaction., PMID:38347421
Molecular Dynamics Simulation and Docking of MUC1 O-Glycopeptide., PMID:38347427
Distinguishing two distinct types of salivary extracellular vesicles: a potential tool for understanding their pathophysiological roles., PMID:38481961
Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing., PMID:38508723
Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3., PMID:38584178
Unlocking PD-1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression., PMID:38605549
Target-induced DNA nanomachine operation for the detection of proteins., PMID:38669960
Protocol to prepare MUC1 glycopeptide vaccines and evaluate immunization effects in mice., PMID:38691463
Versatile Metal-Organic Framework Incorporating Ag2S for Constructing a Photoelectrochemical Immunosensor for Two Breast Cancer Markers., PMID:38757510
Enhanced synthesis of antibody-functionalized gold nanoparticles for multiplexed exosome detection via mass signal amplification in LDI-TOF MS., PMID:38780862
Realization of high-performance biosensor through sandwich analysis utilizing weak value amplification., PMID:38830277
Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants., PMID:38864844
Comparative analysis of renal decline rates in microscopic polyangiitis: unveiling the slowly progressive phenotype., PMID:38907617
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine., PMID:38910324
Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes., PMID:38935849
Characterization of human tibrovirus envelope glycoproteins., PMID:38953631
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy., PMID:39105847
A novel immunofluorescence study of Lingual Salivary Glands in the Egyptian Tortoise (Testudo kleinmanni) and its ecological significance., PMID:39137537
Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer., PMID:39154820
Non-Natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity., PMID:39275921
VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response., PMID:39298996
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique., PMID:39317052
Carbon Nitride Nanosheets as an Adhesive Layer for Stable Growth of Vertically-Ordered Mesoporous Silica Film on a Glassy Carbon Electrode and Their Application for CA15-3 Immunosensor., PMID:39339328
Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines., PMID:39360376
Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions., PMID:39449327
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention., PMID:39450169
Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis., PMID:39450495
Terminal deoxynucleotidyl transferase (TdT) based template-free signal amplification for the detection of exosomes in MUC1-positive cells., PMID:39454542
Ultrasensitive ECL immunoassay for CA15-3 via self-enhanced L012-loaded ZnNi-MOF as an emitter and CeO2-Pt as a co-reaction accelerator., PMID:39489068
Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: A comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis., PMID:39580874
Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure., PMID:39617770
CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation., PMID:39791734
MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer., PMID:39863644
Chemoenzymatic liquid-phase synthesis and immunogenic assessment of tumor-associated complex MUC1 glycopeptide variants., PMID:39892541
Magnetic Cell Separation Based on Protein Nanoparticles Mediating the Interaction between Magnetic Particles and Target Cells., PMID:39910821
Immunofluorescent analysis of exosomes using a microchip filled with transparent antibody-conjugated beads for breast cancer liquid biopsy., PMID:40015783
Study on the Construction and Anti-Tumor Effect of aPDL1/aMUC1 Double Antibody Modification of Doxorubicin Liposome., PMID:40124041
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay., PMID:40148706
Pulse corticosteroid therapy in interstitial lung disease-associated with anti-aminoacyl-tRNA synthetase antibodies: Comparable efficacy with potential for reduced adverse events., PMID:40158665
Structure of the Fab fragment of a humanized 5E5 antibody to a cancer-specific Tn-MUC1 epitope., PMID:40221891
GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growth., PMID:40234452
C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences., PMID:40284463
Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer Immunosurveillance., PMID:40294644
The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma., PMID:40358156
Harnessing MUC1 aptamer-targeted nanoparticles for precision medicine in breast cancer., PMID:40360093
Enhancing Cancer Vaccine Efficacy: Backbone Modification with β‑Amino Acids Alters the Stability and Immunogenicity of MUC1-Derived Glycopeptide Formulations., PMID:40443897
Effective CAR T-cell targeting of an MUC1 cleavage product., PMID:40447312
Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies., PMID:40448390
Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1)., PMID:40489703
For research use only. Not for human or drug use.
